Global Chronic Lymphocytic Leukemia (CLL) Treatment Market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 7.9 Billion in 2017 and is projected to grow at a CAGR of 19% over the forecast period. Chronic Lymphocytic Leukemia is a type of cancer that affects a specific type of white blood cell known as lymphocyte.
The factors such as rising prevalence of leukemia as well as CLL, increasing research & development activities and technological advancements related to the treatment are expected to propel the growth of the market. However, the high cost of treatment and stringent government regulations can hamper the market growth over the forecast period.
Segmentation:
The Global Chronic Lymphocytic Leukemia Treatment Market has been segmented into type, treatment and end user. The market, on the basis of type, has been segmented into indolent CLL and aggressive CLL.
The market, by treatment, has been segmented into chemotherapy, targeted drug therapy, immunotherapy and bone marrow transplant.
The market, by end user, has been segmented into hospitals & clinics, diagnostic laboratories, research institutes and others.
Key players:
F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, CELGENE CORPORATION, Genmab A/S, Teva Pharmaceutical Industries Ltd., Genentech, Inc., Genzyme Corporation, AbbVie Inc., Gilead, Novartis AG, Johnson & Johnson Services, Inc., AstraZeneca, ONO PHARMACEUTICAL CO., LTD., TG Therapeutics, Inc., Ziopharm Oncology, Inc. and others are some of the key players in the global chronic lymphocytic leukemia treatment market.
Global Chronic Lymphocytic Leukemia Treatment Market, by Type:
- Indolent CLL
- Aggressive CLL
Global Chronic Lymphocytic Leukemia Treatment Market, by Treatment:
- Chemotherapy
- Targeted Drug Therapy
- Immunotherapy
- Bone Marrow Transplant
Global Chronic Lymphocytic Leukemia Treatment Market, by End User:
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Others
Request Customization
Get a Sample
Get a Sample
Request Customization